Lawsuit Seeks Expanded Medicare Reimbursement For CGM
Executive Summary
A law firm has filed a class action suit against the US Department of Health and Human Services trying to force broader Medicare reimbursement of continuous glucose monitors. Currently, federal health programs will only cover specific types and uses of the diabetes treatment technology.
You may also be interested in...
Abbott 'No-Fingerstick' CGM System For Diabetes Wins Medicare Coverage
The first continuous glucose monitoring (CGM) system for diabetics that avoids fingerstick calibrations, the Abbott Freestyle Libre, now will be covered through Medicare under therapeutic CGM systems reimbursement codes.
Dexcom First To CGM Reimbursement Finish Line
Following a recent approval for their G5 continuous glucose monitor for use in children and adults without a finger stick, Dexcom has scored big with a new US Centers for Medicaid and Medicare Services policy that would make their CGM the first of its kind eligible for reimbursement from the agency.
‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports
The US FDA has issued a pair of reports focused on device safety and innovation. The reports describe recent steps the agency has taken to improve in the two areas, and what it plans to do next.